| Binocrit 5 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/9-10 |
Recombinant human erythropoietin alfa |
Sandoz GmbH |
— |
| Binocrit 6 000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/410/11-12 |
Recombinant human erythropoietin alfa |
Sandoz GmbH |
— |
| Binocrit 8 000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/410/13-014 |
Recombinant human erythropoietin alfa |
Sandoz GmbH |
— |
| Biopoin 1,000 IU/0.5 ml solution for injection in pre-filled syringe EU/1/09/565/1-2 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 10,000 IU/1 ml solution for injection in pre-filled syringe EU/1/09/565/11-16 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 2,000 IU/0.5 ml solution for injection in pre-filled syringe EU/1/09/565/3-4 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 20,000 IU/1 ml solution for injection in pre-filled syringe EU/1/09/565/17-22 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 3,000 IU/0.5 ml solution for injection in pre-filled syringe EU/1/09/565/5-6 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 30,000 IU/1 ml solution for injection in pre-filled syringe EU/1/09/565/23-28 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 4,000 IU/0.5 ml solution for injection in pre-filled syringe EU/1/09/565/7-8 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| Biopoin 5,000 IU/0.5 ml solution for injection in pre-filled syringe EU/1/09/565/9-10 |
Xm01 drug substance epoetin theta |
TEVA GmbH |
— |
| BiResp Spiromax 160 micrograms/4.5 micrograms inhalation powder EU/1/14/921/001-003 |
Budesonide, Formoterol fumarate dihydrate |
Teva Pharma B.V. |
— |
| BiResp Spiromax 320 micrograms/9 micrograms inhalation powder EU/1/14/921/004-006 |
Budesonide, Formoterol fumarate dihydrate |
Teva Pharma B.V. |
— |
| BLENREP 100 mg powder for concentrate for solution for infusion EU/1/25/1948/002 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| BLENREP 70 mg powder for concentrate for solution for infusion EU/1/25/1948/001 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion EU/1/15/1047/001 |
Blinatumomab |
Amgen Europe B.V., |
— |
| Blitzima 100 mg concentrate for solution for infusion EU/1/17/1205/001-002 |
Rituximab |
Celltrion Healthcare Hungary Kft. |
— |
| BOCOUTURE 100 units powder for solution for injection PA1907/003/002 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| BOCOUTURE 50 units powder for solution for injection PA1907/003/001 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| BOMYNTRA 120 mg solution for injection in pre-filled syringe EU/1/25/1953/04-06 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| BOMYNTRA 120 mg solution for injection in vial EU/1/25/1953/01-03 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| Bonasol Once Weekly 70 mg Oral Solution PA1572/001/001 |
Alendronate sodium trihydrate |
Xeolas Pharmaceuticals Limited |
Marketed |
| Bondronat 2 mg concentrate for solution for infusion. EU/1/96/012/004 |
Ibandronic acid monosodium monohydrate |
Atnahs Pharma Netherlands B.V. |
— |
| Bondronat 50 mg film-coated tablets EU/1/96/012/009-010 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bondronat 6 mg concentrate for solution for infusion EU/1/96/012/011-13 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bonviva 150 mg film-coated tablets EU/1/03/265/3-4 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bonviva 3 mg solution for injection EU/1/03/265/5-6 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bortezomib 3.5 mg powder for solution for injection PA23250/003/001 |
Bortezomib |
MSN Labs Europe Limited |
Marketed |
| Bortezomib Accord 1 mg Powder for solution for injection EU/1/15/1019/002 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Accord 2.5 mg/ml Solution for injection EU/1/15/1019/003-006 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Accord 3.5 mg Powder for solution for injection EU/1/15/1019/001 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Fresenius Kabi 3.5 mg powder for solution for injection EU/1/19/1397/001 |
Bortezomib |
Fresenius Kabi Deutschland GmbH |
— |
| Bortezomib SUN 3.5 mg powder for solution for injection EU/1/16/1102/001 |
Bortezomib |
Sun Phamaceutical Industries Europe B.V. |
— |
| Bosulif 100 mg film-coated tablets EU/1/13/818/001-002 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 100 mg hard capsules EU/1/13/818/009 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 400 mg film-coated tablets EU/1/13/818/006-007 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 50 mg hard capsules EU/1/13/818/008 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Bosulif 500 mg film-coated tablets EU/1/13/818/003-004 |
Bosutinib monohydrate |
Pfizer Europe MA EEIG |
— |
| Braftovi 50 mg Hard capsule EU/1/18/1314/001 |
ENCORAFENIB |
Pierre Fabre Medicament |
— |
| Braftovi 75 mg Hard capsule EU/1/18/1314/002 |
ENCORAFENIB |
Pierre Fabre Medicament |
— |
| Bramitob 300mg/4ml Nebuliser Solution PA0584/007/001 |
Tobramycin |
Chiesi Farmaceutici S.p.A. |
Marketed |
| Bretaris Genuair 322 micrograms inhalation powder EU/1/12/781/001-003 |
Micronized aclidinium bromide |
Covis Pharma Europe B.V. |
— |
| Brevoxyl 40 mg/g cream PA23354/001/001 |
Benzoyl Peroxide |
Avianta Pharma EU Limited |
Not marketed |
| Breyanzi 1.1-70 x 10^6 cells/mL/1.1-70 x 10^6 cells/mL dispersion for infusion EU/1/22/1631/001 |
Lisocabtagene Maraleucel |
Celgene Europe B.V. |
— |
| Bridion 100 mg/ml solution for injection EU/1/08/466/1-2 |
Sugammadex |
Merck Sharp & Dohme BV |
— |
| Brilique 60 mg film-coated tablets EU/1/10/655/007-011 |
Ticagrelor |
AstraZeneca AB |
— |
| Brilique 90 mg film-coated tablets EU/1/10/655/001-006 |
Ticagrelor |
AstraZeneca AB |
— |
| Brilique 90 mg orodispersible tablets EU/1/10/655/012-014 |
Ticagrelor |
AstraZeneca AB |
— |
| Brimica Genuair 340 micrograms /12 micrograms inhalation powder EU/1/14/963/001-003 |
Micronized formoterol fumarate dihydrate, Micronized aclidinium bromide |
Covis Pharma Europe B.V. |
— |
| BRINAVESS 20 mg/ml concentrate for solution for infusion EU/1/10/645/001-002 |
Vernakalant hydrochloride |
Correvio |
— |